Cargando…
Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study
BACKGROUND: Aspirin has been proposed as a novel adjuvant agent in colorectal cancer (CRC). Six observational studies have reported CRC-specific survival outcomes in patients using aspirin after CRC diagnosis but the results from these studies have been conflicting. Using a population-based cohort d...
Autores principales: | Gray, Ronan T., Coleman, Helen G., Hughes, Carmel, Murray, Liam J., Cardwell, Chris R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389196/ https://www.ncbi.nlm.nih.gov/pubmed/29486728 http://dx.doi.org/10.1186/s12885-018-4142-y |
Ejemplares similares
-
Low-dose aspirin and survival from lung cancer: a population-based cohort study
por: Mc Menamin, Úna C., et al.
Publicado: (2015) -
Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink
por: Murray, Liam J, et al.
Publicado: (2014) -
Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts
por: Cardwell, Chris R, et al.
Publicado: (2014) -
Statin use and breast cancer survival: a nationwide cohort study in Scotland
por: Mc Menamin, Úna C., et al.
Publicado: (2016) -
Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
por: Gray, Ronan T, et al.
Publicado: (2017)